Drug intelligence / Profile preview

YSJP formula

Development stage: Unknown
Lead developer: Beijing Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

YSJP formula is a Traditional Chinese Medicine (TCM) herbal composition developed by the Beijing Hospital of Traditional Chinese Medicine, affiliated with Capital Medical University. It is primarily investigated for the treatment of polycystic ovary syndrome (PCOS) associated with insulin resistance. The formula's name, YSJP, is derived from the TCM therapeutic principle of 'Yi Shen Jian Pi' (tonifying the kidney and strengthening the spleen). Research indicates that the formula may exert its effects by modulating metabolic and reproductive functions, specifically through the regulation of serum exosomal microRNA (miRNA) profiles and the improvement of insulin sensitivity and hormonal balance.

Other names: YSJP decoctionYi Shen Jian Pi formula

Beyond the preview

Go deeper on YSJP formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on YSJP formula.

Explore the full profile